Quest Diagnostics Retained Earnings (Accumulated Deficit) 2010-2024 | DGX

Quest Diagnostics retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $9.222B, a 5.87% increase year-over-year.

  • Quest Diagnostics retained earnings (accumulated deficit) for 2023 were $8.825B, a 6.45% increase from 2022.
  • Quest Diagnostics retained earnings (accumulated deficit) for 2022 were $8.29B, a 8.38% increase from 2021.
  • Quest Diagnostics retained earnings (accumulated deficit) for 2021 were $7.649B, a 17.78% decline from 2020.

Quest Diagnostics Retained Earnings (Accumulated Deficit) 2010-2024 | DGX

  • Quest Diagnostics retained earnings (accumulated deficit) for 2023 were $8.825B, a 6.45% increase from 2022.
  • Quest Diagnostics retained earnings (accumulated deficit) for 2022 were $8.29B, a 8.38% increase from 2021.
  • Quest Diagnostics retained earnings (accumulated deficit) for 2021 were $7.649B, a 17.78% decline from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.4B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$7B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$3.8B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.8B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$237M
Daxor (DXR)$46M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$11M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M